Possible Involvement of TGF‑β‑SMAD‑mediated Epithelial‑mesenchymal Transition in Pro‑metastatic Property of PAX6

Overview

Journal Oncol Rep

Specialty Oncology

Date 2020 Jul 7

PMID 32627030

Citations 7

Authors

Meng Jin

Daili Gao

Rongchun Wang

Attila Sik

Kechun Liu

Affiliations

Soon will be listed here.

Abstract

Paired box 6 (PAX6) is a transcription factor that has oncogenic features. In breast cancer, PAX6 facilitates tumor progression; however, the underlying mechanism is largely unknown. The majority of breast cancer‑related mortalities are associated with metastasis of cancer cells. Therefore, the present study aimed to investigate the role of PAX6 in breast tumor metastasis. PAX6 was stably overexpressed in breast cancer cells to perform tumor migration and metastasis assays in vitro and in vivo. In addition, the expression of PAX6 and transforming growth factor β (TGF‑β)‑SMAD signaling associated proteins on human breast cancer tissue array, as well as key factors involved in epithelial‑mesenchymal transition (EMT) were assayed to explore the mechanism underlying metastasis of breast cancer cells. The expression levels of PAX6 were demonstrated to be increased in human breast cancer tissues and associated with poor clinical outcomes. Overexpression of PAX6 markedly promoted metastasis. Further investigation revealed that PAX6 overexpression increased TGF‑β‑SMAD signaling pathway and induced EMT. These results suggested that highly expressed PAX6 led to EMT through TGF‑β‑SMAD signaling pathway, thereby promoting cell metastasis and ultimately affecting survival in patients with breast cancer. Taken together, findings indicated that PAX6 may serve as a therapeutic target for the clinical treatment of breast cancer and the underlying mechanism could be used to overcome metastasis of cancer cells.

Citing Articles

Exosomal noncoding RNAs: decoding their role in thyroid cancer progression.

Sun W, Jiang C, Liu Q, Wang N, Huang R, Jiang G Front Endocrinol (Lausanne). 2024; 15:1337226.

PMID: 38933820 PMC: 11199389. DOI: 10.3389/fendo.2024.1337226.

Brain organoid-on-chip system to study the effects of breast cancer derived exosomes on the neurodevelopment of brain.

Cui K, Chen W, Cao R, Xie Y, Wang P, Wu Y Cell Regen. 2022; 11(1):7.

PMID: 35254502 PMC: 8901935. DOI: 10.1186/s13619-021-00102-7.

KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Rudd M, Hansen N, Zhang X, Urick M, Zhang S, Merino M PLoS One. 2022; 17(1):e0251286.

PMID: 35081118 PMC: 8791453. DOI: 10.1371/journal.pone.0251286.

Unilateral zebrafish corneal injury induces bilateral cell plasticity supporting wound closure.

Ikkala K, Stratoulias V, Michon F Sci Rep. 2022; 12(1):161.

PMID: 34997071 PMC: 8741998. DOI: 10.1038/s41598-021-04086-x.

Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.

Lin Q, Qi Q, Hou S, Chen Z, Jiang N, Zhang L Bioengineered. 2021; 12(2):10136-10149.

PMID: 34866540 PMC: 8809932. DOI: 10.1080/21655979.2021.2000745.

References

Zhang B, Wang L, Ji X, Zhang S, Sik A, Liu K . Anti-Inflammation Associated Protective Mechanism of Berberine and its Derivatives on Attenuating Pentylenetetrazole-Induced Seizures in Zebrafish. J Neuroimmune Pharmacol. 2020; 15(2):309-325. DOI: 10.1007/s11481-019-09902-w. View

Wu Y, Sarkissyan M, Vadgama J . Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med. 2016; 5(2). PMC: 4773769. DOI: 10.3390/jcm5020013. View

Peart O . Metastatic Breast Cancer. Radiol Technol. 2017; 88(5):519M-539M. View

Xie F, Ling L, van Dam H, Zhou F, Zhang L . TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2017; 50(1):121-132. DOI: 10.1093/abbs/gmx123. View

Rojas A, Padidam M, Cress D, Grady W . TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. Biochim Biophys Acta. 2009; 1793(7):1165-73. PMC: 2700179. DOI: 10.1016/j.bbamcr.2009.02.001. View

Imamura T, Hikita A, Inoue Y . The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis. Breast Cancer. 2011; 19(2):118-24. DOI: 10.1007/s12282-011-0321-2. View

Farabaugh S, Micalizzi D, Jedlicka P, Zhao R, Ford H . Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene. 2011; 31(5):552-62. PMC: 3183358. DOI: 10.1038/onc.2011.259. View

Lacroix M, Leclercq G . Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat. 2004; 83(3):249-89. DOI: 10.1023/B:BREA.0000014042.54925.cc. View

Pappu K, Mardon G . Genetic control of retinal specification and determination in Drosophila. Int J Dev Biol. 2004; 48(8-9):913-24. DOI: 10.1387/ijdb.041875kp. View

10.

Meng Y, Zou Q, Liu T, Cai X, Huang Y, Pan J . microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells. Mol Med Rep. 2014; 11(1):379-85. DOI: 10.3892/mmr.2014.2684. View

11.

Hoshiyama D, Iwabe N, Miyata T . Evolution of the gene families forming the Pax/Six regulatory network: isolation of genes from primitive animals and molecular phylogenetic analyses. FEBS Lett. 2007; 581(8):1639-43. DOI: 10.1016/j.febslet.2007.03.027. View

12.

Zou Q, Yi W, Huang J, Fu F, Chen G, Zhong D . MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells. Exp Ther Med. 2017; 14(2):1198-1204. PMC: 5525589. DOI: 10.3892/etm.2017.4593. View

13.

Zhang J, Lu J, Suter D, Krause K, Fini M, Chen B . Isoform- and dose-sensitive feedback interactions between paired box 6 gene and delta-catenin in cell differentiation and death. Exp Cell Res. 2010; 316(6):1070-81. PMC: 2885963. DOI: 10.1016/j.yexcr.2010.01.006. View

14.

Huang Z, Duan H, Li H . Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools. Biomed Res Int. 2015; 2015:878546. PMC: 4630377. DOI: 10.1155/2015/878546. View

15.

Singha P, Pandeswara S, Geng H, Lan R, Venkatachalam M, Dobi A . Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer. Genes Cancer. 2019; 10(5-6):134-149. PMC: 6872668. DOI: 10.18632/genesandcancer.194. View

16.

Lv W, Wang J, Zhang S . Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma. Oncol Lett. 2019; 18(5):5325-5331. PMC: 6781646. DOI: 10.3892/ol.2019.10859. View

17.

Lai J, Mertens R, Mirocha J, Koo J, Venturina M, Chung F . Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors. Endocr Pathol. 2014; 26(1):54-62. DOI: 10.1007/s12022-014-9346-3. View

18.

Xia X, Yin W, Zhang X, Yu X, Wang C, Xu S . PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer. Oncol Lett. 2015; 10(3):1501-1506. PMC: 4533256. DOI: 10.3892/ol.2015.3434. View

19.

Khoshakhlagh M, Soleimani A, Moradi Binabaj M, Avan A, Ferns G, Khazaei M . Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer. Biochem Pharmacol. 2019; 164:17-22. DOI: 10.1016/j.bcp.2019.03.031. View

20.

Buck M, Knabbe C . TGF-beta signaling in breast cancer. Ann N Y Acad Sci. 2007; 1089:119-26. DOI: 10.1196/annals.1386.024. View